Tier 3 · Filer Universe
Foghorn Therapeutics Inc.
FHTX · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$6.87
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001822462
Liquidity rank
#3363
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $30.91M | 2025-12-31 | 0001628280-26-016814 |
| Annual diluted EPS | -1.18 | 2025-12-31 | 0001628280-26-016814 |
| Quarterly revenue | $16.07M | 2026-06-30 | 0001628280-26-053819 |
| Quarterly diluted EPS | -0.1 | 2026-06-30 | 0001628280-26-053819 |
SEC EDGAR Frames batch generated 2026-08-24T22:57:10.515Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames